Joseph Bosco III, MD
Vice Chair, NYU Hospital For Joint Diseases Department of Orthopedic Surgery
New York, NY
Dr. Joseph Bosco is Vice Chairman for Clinical Affairs of the NYUHJD Department of Orthopedic Surgery, and Associate Professor of Orthopedic Surgery at New York University Medical Center. He is currently the director for the Center for Quality and Patient Safety at the Hospital for Joint Diseases. He was the associate director of the New York University / Hospital for Joints Diseases Orthopedic Residency Program from 2000 – 2005.
Dr. Bosco has served as team physician for the Durham Bulls and Brooklyn Cyclones minor league baseball teams. From 2002 until 2004, he was a team physician for the New York Mets professional baseball team. He currently serves a team physician for several area high schools. He is a member of and held leadership positions in numerous professional societies, including The American Orthopedic Society for Sports Medicine (former member Board of Councilors), The American Orthopedic Association, The American Academy of Orthopedic Surgery (Current BOD member), The New York Academy of Medicine, The Eastern Orthopedic Association and the New York State Society of Orthopedic Surgeons (former BOD member). He was chosen to, and completed, the prestigious American Academy of Orthopedic Surgery Leadership Fellows Program.
Dr. Bosco attended Medical School at the University of Vermont, and completed a residency in Orthopedic Surgery at The University of North Carolina at Chapel Hill. He then obtained a one year fellowship at The University of Arizona. Upon completion of his fellowship he returned to New York and began practice at Albert Einstein College of Medicine where he received an award as outstanding faculty in orthopedic surgery. In 1998, he joined the Orthopedics department at New York University, where he remains today. He has published and lectured, both nationally and internationally, on a variety of quality and infection prevention and control topics. Most recently his paper entitled;” Modifiable risks of Infection following THR”, won the Otto Aufranc Award at the Hip Society annual meeting.